Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-02-09 11:40 am Purchase |
2022-12-31 | 13G | Guild Holdings Company GHLD |
ADAGE CAPITAL PARTNERS GP LLC | 1,161,253 5.600% |
85,848![]() (+7.98%) |
Filing History |
2023-02-09 11:39 am Sale |
2022-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
ADAGE CAPITAL PARTNERS GP LLC | 1,120,000 2.150% |
-1,030,000![]() (-47.91%) |
Filing History |
2023-02-09 11:38 am Purchase |
2022-12-31 | 13G | Finance Of America Companies Inc. FOA |
ADAGE CAPITAL PARTNERS GP LLC | 353,880 5.620% |
10,700![]() (+3.12%) |
Filing History |
2023-02-09 11:12 am Unchanged |
2022-12-31 | 13G | Arena Fortify Acquisition Corp. AFAC |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
2023-02-09 11:11 am Unchanged |
2022-12-31 | 13G | Crypto 1 Acquisition Corp DAOO |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
2023-02-09 11:09 am Unchanged |
2022-12-31 | 13G | Colicity Inc. COLI |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
2023-02-09 11:07 am Sale |
2022-12-31 | 13G | Omega Alpha SPAC OMEG |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
-1,030,770![]() (Position Closed) |
Filing History |
2023-02-09 11:07 am Sale |
2022-12-31 | 13G | Provention Bio, Inc. PRVB |
ADAGE CAPITAL PARTNERS GP LLC | 2,519,257 2.890% |
-2,780,743![]() (-52.47%) |
Filing History |
2023-02-09 11:06 am Sale |
2022-12-31 | 13G | Royalty Pharma plc RPRX |
ADAGE CAPITAL PARTNERS GP LLC | 7,000,000 1.590% |
-17,842,715![]() (-71.82%) |
Filing History |
2023-02-09 11:05 am Purchase |
2022-12-31 | 13G | Mammoth Energy Services, Inc. TUSK |
ADAGE CAPITAL PARTNERS GP LLC | 3,127,268 6.610% |
276,194![]() (+9.69%) |
Filing History |
2023-02-09 11:05 am Unchanged |
2022-12-31 | 13G | Akili, Inc. AKLI |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
2023-02-09 11:04 am Sale |
2022-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
ADAGE CAPITAL PARTNERS GP LLC | 2,600,000 4.050% |
-1,327,000![]() (-33.79%) |
Filing History |
2023-02-09 11:03 am Purchase |
2022-12-31 | 13G | OPAL Fuels Inc. OPAL |
ADAGE CAPITAL PARTNERS GP LLC | 494,233 1.930% |
494,233![]() (New Position) |
Filing History |
2023-02-09 11:02 am Purchase |
2022-12-31 | 13G | Vinci Partners Investments Ltd. VINP |
ADAGE CAPITAL PARTNERS GP LLC | 3,161,881 7.450% |
234,950![]() (+8.03%) |
Filing History |
2023-02-09 11:01 am Unchanged |
2022-12-31 | 13G | Tuesday Morning Corporation TUEMQ |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
2023-02-09 11:00 am Unchanged |
2022-12-31 | 13G | SPREE ACQUISITION CORP 1 LTD SACQF |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
2023-02-09 10:58 am Purchase |
2022-12-31 | 13G | TPB Acquisition Corporation I TPBA |
ADAGE CAPITAL PARTNERS GP LLC | 525,000 2.910% |
525,000![]() (New Position) |
Filing History |
2023-02-09 10:57 am Sale |
2022-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
-93,333![]() (Position Closed) |
Filing History |
2023-02-09 10:56 am Purchase |
2022-12-31 | 13G | Aura Biosciences, Inc. AURA |
ADAGE CAPITAL PARTNERS GP LLC | 2,132,739 5.760% |
42,074![]() (+2.01%) |
Filing History |
2023-02-09 10:55 am Sale |
2022-12-31 | 13G | Amalgamated Financial Corp. AMAL |
ADAGE CAPITAL PARTNERS GP LLC | 1,620,631 5.280% |
-122,796![]() (-7.04%) |
Filing History |